C1 inhibitor (human) [C1 INH]
0624-400
Approved mab completed
Quick answer
C1 inhibitor (human) [C1 INH] for Hereditary Angioedema is a Approved program (mab) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Hereditary Angioedema
- Phase
- Approved
- Modality
- mab
- Status
- completed